recombinant tissue plasminogen activator (tnk-t-pa) for injection 40 mg
A third-generation thrombolytic agent produced by recombinant DNA technology. It has a high affinity for fibrin, allowing it to target and dissolve clots specifically within the coronary arteries with a lower risk of systemic bleeding compared to older thrombolytics.
recombinant tissue plasminogen activator (tnk-t-pa) for injection 40 mg
By GENNOVA BIOPHARMACEUTICALS LIMITED
Our Price
₹53,829.92Strength
40 mg
Packaging
Single-dose kit containing 1 vial of lyophilized powder and 1 pre-filled syringe of sterile water for injection (usually 8 ml or 10 ml).
Type
Vial and Pre-filled Syringe Kit packed in a cardboard box.
Shelf Life
24 to 36 months
Manufacturer Info
Global Compliance
Our products strictly adhere to International Safety Protocols. 2M Pharmaceuticals ensures 100% genuine supply chain monitoring for all export orders.
RECOMBINANT TISSUE PLASMINOGEN ACTIVATOR (TNK-t-PA) FOR INJECTION 40 mg
₹53,829.92